Nucleophosmin regulates the stability and transcriptional activity of p53

被引:0
|
作者
Emanuela Colombo
Jean-Christophe Marine
Davide Danovi
Brunangelo Falini
Pier Giuseppe Pelicci
机构
[1] European Institute of Oncology,Department of Experimental Oncology
[2] Institutes of Haematology and Internal Medicine,undefined
[3] University of Perugia,undefined
[4] FIRC Institute of Molecular Oncology (IFOM),undefined
来源
Nature Cell Biology | 2002年 / 4卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Nucleophosmin (NPM) is a ubiquitously expressed nucleolar phosphoprotein that continuously shuttles between the nucleus and cytoplasm1. It has been proposed to function in ribosomal protein assembly and transport2, and also as a molecular chaperone that prevents proteins from aggregating in the crowded environment of the nucleolus3. The NPM gene is involved in several tumour-associated chromosome translocations, which have resulted in the formation of fusion proteins that retain the amino terminus of NPM, including NPM–ALK4, NPM–RAR5 and NPM–MLF1 (ref. 6). It is generally thought that the NPM component is not involved in the transforming potential of these fusion proteins7, but instead provides a dimerization interface for the oligomerization and the oncogenic conversion of the various NPM partners (ALK, RAR, MLF1). Here we show that NPM interacts directly with the tumour suppressor p53, regulates the increase in stability and transcriptional activation of p53 after different types of stress, and induces p53-dependent premature senescence on overexpression in diploid fibroblasts. These findings indicate that NPM is a crucial regulator of p53 and suggest that alterations of the NPM function by NPM fusion proteins might lead to deregulation of p53 in tumours.
引用
收藏
页码:529 / 533
页数:4
相关论文
共 50 条
  • [41] Nucleophosmin Blocks Mitochondrial Localization of p53 and Apoptosis
    Dhar, Sanjit Kumar
    St Clair, Daret K.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (24) : 16409 - 16418
  • [42] Modulation of p53 transcriptional activity by Delta40p53, a p53 isoform lacking the transactivation domain
    Hafsi, Hind
    Marcel, Virginie
    Hainaut, Pierre
    BULLETIN DU CANCER, 2011, 98 : S13 - S14
  • [43] INACTIVE P53 MUTANTS MAY ENHANCE THE TRANSCRIPTIONAL ACTIVITY OF WILD-TYPE P53
    ZHANG, W
    SHAY, JW
    DEISSEROTH, A
    CANCER RESEARCH, 1993, 53 (20) : 4772 - 4775
  • [44] Tumour associated mutants of p53 can inhibit transcriptional activity of p53 without heterooligomerization
    Joers, A
    Kristjuhan, A
    Kadaja, L
    Maimets, T
    ONCOGENE, 1998, 17 (18) : 2351 - 2358
  • [45] Tumour associated mutants of p53 can inhibit transcriptional activity of p53 without heterooligomerization
    A Jõers
    A Kristjuhan
    L Kadaja
    T Maimets
    Oncogene, 1998, 17 : 2351 - 2358
  • [46] Transcriptional Regulation by p53
    Beckerman, Rachel
    Prives, Carol
    COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY, 2010, 2 (08): : a000935
  • [47] The circadian factor Period 2 modulates p53 stability and transcriptional activity in unstressed cells
    Gotoh, T.
    Vila-Caballer, M.
    Santosa, C. S.
    Liu, J.
    Yang, J.
    Finkielstein, C. V.
    MOLECULAR BIOLOGY OF THE CELL, 2014, 25
  • [48] The circadian factor Period 2 modulates p53 stability and transcriptional activity in unstressed cells
    Gotoh, Tetsuya
    Vila-Caballer, Marian
    Santos, Carlo S.
    Liu, Jingjing
    Yang, Jianhua
    Finkielstein, Carla V.
    MOLECULAR BIOLOGY OF THE CELL, 2014, 25 (19) : 3081 - 3093
  • [49] Transcriptional coactivator TAZ negatively regulates tumor-suppressor p53 activity and cellular senescence
    Inoue, Yasumichi
    Hayashi, Hidetoshi
    CANCER SCIENCE, 2018, 109 : 735 - 735
  • [50] An uORF in p53 mRNA regulates translation and mRNA stability
    Carastro, L. Michael
    Gandikal, Naz
    Brucklacher, Robert
    Lazarus, Philip
    FASEB JOURNAL, 2007, 21 (05): : A652 - A652